Dr. Aseem Malhotra

And then they'll say, well, is there anything else I can do?

And of course, you and I are empowered with an understanding lifestyle, right?

So this is how we should be practicing medicine.

But Mark, one quick thing is that I didn't just talk about this.

I wrote about it.

And I even got this in front of every Royal College president in the UK saying that the British Medical Journal were doing this campaign against too much medicine.

They're talking about informed consent by use of NNTs.

We need to launch a campaign because overprescription is a big problem.

We know there's a big problem with side effects.

We know that one estimate suggests that prescribed medications is a third most common cause of death after heart disease and cancer globally because of side effects.

It didn't take long for me to convince the Royal College presidents.

I was an ambassador for the overall Academy of Royal Colleges at the time.

and to say that we should have a joint campaign with the BMJ.

So I then wrote a paper, I was lead author, I had the chairman of the General Medical Council, the chairman of the medical colleges on that co-author paper, to say, okay, this is a campaign we can get and change medical education, change postgraduate medical training.

And we got this in the media, it was a big news story, BBC, all over the news,

front page of British newspapers, campaigns obviously need to be sustained.

But what happened is, of course, if you engage in true informed consent with patients, most patients will choose less treatments.

Now, who's going to suffer from that?

The drug industry.

In my view, it's very clear.